3,4-Difluoroaniline CAS 3863-11-4 serves as a critical building block in the API intermediates market, where its 99% pharma-grade purity is essential for synthesizing advanced kinase inhibitors and neurological drug candidates. 1-Amino-3,4-difluorobenzene is increasingly sought after by global CDMO partners who require...